These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 18623204)

  • 1. Forced degradation of betamethasone sodium phosphate under solid state: Formation, characterization, and mechanistic study of all four 17,20-diastereomers of betamethasone 17-deoxy-20-hydroxy-21-oic acid.
    Li M; Wang X; Chen B; Chan TM; Rustum A
    J Pharm Sci; 2009 Mar; 98(3):894-904. PubMed ID: 18623204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid structure elucidation of drug degradation products using mechanism-based stress studies in conjunction with LC-MS(n) and NMR spectroscopy: identification of a photodegradation product of betamethasone dipropionate.
    Lin M; Li M; Buevich AV; Osterman R; Rustum AM
    J Pharm Biomed Anal; 2009 Oct; 50(3):275-80. PubMed ID: 19525081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of liquid chromatography/tandem mass spectrometric molecular fingerprinting for the rapid structural identification of pharmaceutical impurities.
    Li M; Wang X; Chen B; Lin M; Buevich AV; Chan TM; Rustum AM
    Rapid Commun Mass Spectrom; 2009 Nov; 23(22):3533-42. PubMed ID: 19844969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural identification and characterization of potential degradants of zotarolimus on zotarolimus-coated drug-eluting stents.
    Chen Q; Zielinski D; Chen J; Nowak S; Zhou CC
    J Pharm Biomed Anal; 2009 Dec; 50(5):778-86. PubMed ID: 19581067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of LC-MS(n) in conjunction with mechanism-based stress studies in the elucidation of drug impurity structure: rapid identification of a process impurity in betamethasone 17-valerate drug substance.
    Li M; Lin M; Rustum A
    J Pharm Biomed Anal; 2008 Dec; 48(5):1451-6. PubMed ID: 18977106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Forced degradation and impurity profiling: recent trends in analytical perspectives.
    Jain D; Basniwal PK
    J Pharm Biomed Anal; 2013 Dec; 86():11-35. PubMed ID: 23969330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism driven structural elucidation of forced degradation products from hydrocortisone in solution.
    Zhang F; Zhou J; Shi Y; Tavlarakis P; Karaisz K
    J Pharm Biomed Anal; 2016 Sep; 128():333-341. PubMed ID: 27328360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dry heat forced degradation of buserelin peptide: kinetics and degradant profiling.
    D'Hondt M; Fedorova M; Peng CY; Gevaert B; Taevernier L; Hoffmann R; De Spiegeleer B
    Int J Pharm; 2014 Jun; 467(1-2):48-9. PubMed ID: 24657556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation and structure determination of oxidative degradation products of atorvastatin.
    Kracun M; Kocijan A; Bastarda A; Grahek R; Plavec J; Kocjan D
    J Pharm Biomed Anal; 2009 Dec; 50(5):729-36. PubMed ID: 19615842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative study of enol aldehyde formation from betamethasone, dexamethasone, beclomethasone and related compounds under acidic and alkaline conditions.
    Chen B; Li M; Lin M; Tumambac G; Rustum A
    Steroids; 2009 Jan; 74(1):30-41. PubMed ID: 18938190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of LC-MS/TOF, LC-MS(n), NMR and LC-NMR in characterization of stress degradation products: Application to cilazapril.
    Narayanam M; Sahu A; Singh S
    J Pharm Biomed Anal; 2015; 111():190-203. PubMed ID: 25890215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Forced Oxidative Degradation Pathways of the Imidazole Moiety of Daclatasvir.
    Huang Y; Su BN; Marshall J; Miller SA
    J Pharm Sci; 2019 Oct; 108(10):3312-3318. PubMed ID: 31145924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. UVB photolysis of betamethasone and its esters: characterization of photoproducts in solution, in pig skin and in drug formulations.
    Miolo G; Gallocchio F; Levorato L; Dalzoppo D; Beyersbergen van Henegouwen GM; Caffieri S
    J Photochem Photobiol B; 2009 Jul; 96(1):75-81. PubMed ID: 19450988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of low-level degradants from low dose tablets.
    Blanchard A; Lee C; Nickerson B; Lohr LL; Jensen AJ; Alsante KM; Sharp TR; Santafianos DP; Morris R; Snyder KD
    J Pharm Biomed Anal; 2004 Oct; 36(2):265-75. PubMed ID: 15496319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LC-MS/MS determination of betamethasone and its phosphate and acetate esters in human plasma after sample stabilization.
    Salem II; Alkhatib M; Najib N
    J Pharm Biomed Anal; 2011 Dec; 56(5):983-91. PubMed ID: 21855245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive strategy for the rapid structure elucidation of drug degradants.
    Rourick RA; Volk KJ; Klohr SE; Spears T; Kerns EH; Lee MS
    J Pharm Biomed Anal; 1996 Sep; 14(12):1743-52. PubMed ID: 8887722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural elucidation of two novel degradants of lurasidone and their formation mechanisms under free radical-mediated oxidative and photolytic conditions via liquid chromatography-photodiode array/ultraviolet-tandem mass spectrometry and one-dimensional/two-dimensional nuclear magnetic resonance spectroscopy.
    Wang KC; Guo Q; Kuang Z; Jin J; Li D; Chen W; Zhu W; Li M
    J Mass Spectrom; 2022 Jul; 57(7):e4871. PubMed ID: 35739062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure elucidation of novel degradation products of thiocolchicoside by NMR spectroscopy.
    Mutha VVSRNAK; RavichandraReddy VV; Achanta PS; Rendedula D; Chandra C; Shaik NM; Kaliyaperumal M; Korupolu RB; Gajbhiye SB; Rumalla CS
    J Pharm Biomed Anal; 2019 Apr; 167():49-58. PubMed ID: 30739051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early prediction of pharmaceutical oxidation pathways by computational chemistry and forced degradation.
    Reid DL; Calvitt CJ; Zell MT; Miller KG; Kingsmill CA
    Pharm Res; 2004 Sep; 21(9):1708-17. PubMed ID: 15497700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Degradation of vitamin D3 in a stressed formulation: the identification of esters of vitamin D3 formed by a transesterification with triglycerides.
    Ballard JM; Zhu L; Nelson ED; Seburg RA
    J Pharm Biomed Anal; 2007 Jan; 43(1):142-50. PubMed ID: 16901672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.